79420853 - AUTOLUS

Information

• Trademark
• 79420853

• Source

• Serial Number

  79420853

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 27, 2025
  8 months ago

• Transaction Date

  July 13, 2025
  3 months ago

• Status Date

  June 21, 2025
  3 months ago

• Status Code

  641

• Current Location

  TMEG LAW OFFICE 103

  Employee Name

  HARMON, RAYMOND

• Law Office Assigned Location Code

  L30

• Owners

  • Autolus Limited C/O Syncona Partners

Case File Statements

• GS0401: Custom manufacture of therapeutic drugs, namely cell therapies, preparations to treat autoimmune diseases, cancer therapies and cancer vaccines.
• GS0051: Medical and veterinary preparations for therapeutic purposes; preparations for cell therapy; preparations for gene therapy; preparations for cancer therapies; preparations for autoimmune diseases; chimeric antigen receptors (CAR) and therapeutic preparations thereof; antibodies; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of autoimmune diseases; biological preparations for the treatment of cancer; biological preparations for use in the treatment of autoimmune diseases; pharmaceutical and biological preparations for immunotherapy, including T cell therapy; vaccines.
• GS0441: Medical services; veterinary services; services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of autoimmune diseases, cancer therapies and cancer vaccines.
• GS0421: Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of autoimmune diseases and new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vaccines, including personalised cancer vaccines; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services.

Case File Event Statements

• 4/3/2025 - 6 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 4/4/2025 - 6 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/4/2025 - 6 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/9/2025 - 6 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/17/2025 - 6 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/18/2025 - 6 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/21/2025 - 3 months ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 6/21/2025 - 3 months ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 7/12/2025 - 3 months ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT